je.st
news
JMP Securities Upgrades BioCryst Pharmaceuticals to Outperform
2013-07-21 14:54:31| Biotech - Topix.net
The firm currently has a $3.00 price objective on the stock. JMP Securities' price target would indicate a potential upside of 21.95% from the stock's previous close.
Tags: securities
upgrades
pharmaceuticals
outperform
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||